Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy

Aristotelis Bamias; Kimon Tzannis; Ioannis Dimitriadis; Georgios Tsironis; Alkistis-Maria Papatheorodidi; Anna Tsiara; Charalampos Fragkoulis; Aikaterini Xirokosta; D. Barbarousi; Georgios Papadopoulos; Roubini Zakopoulou; Ioannis Varkarakis; Iraklis Mitsogiannis; Ioannis Adamakis; Christos Alamanis; Konstantinos Stravodimos; Athanasios Papatsoris; Athanasios Dellis; Alexandros Drivalos; Konstantinos Ntoumas; Haris Matsouka; Panagiotis Halvatsiotis; Athanasios Raptis; Grigoris Gerotziafas; Meletios A Dimopoulos

doi:10.1016/j.clgc.2019.12.021

Related publications

Article2022

Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study

Aristotelis Bamias, Kimon Tzannis, Roubini Zakopoulou, Minas Sakellakis, John Dimitriadis, Alkistis Papatheodoridi, Lοukianos S. Rallidis, Panagiotis Halvatsiotis, Anna Tsiara, Maria Kaparelou, E. Kostouros, Despina Barbarousi, Konstantinos Koutsoukos, Evangelos Fragiadis, Athanasios Dellis, Ιoannis Anastasiou, Konstantinos Stravodimos, Alexandros Pinitas, Athanasios Papatsoris, Ioannis Adamakis, Ioannis Varkarakis, Charalampos Fragoulis, Stamatina Pagoni, Charis Matsouka, Andreas Skolarikos, Dionysios Mitropoulos, Konstantinos Doumas, Charalampos Deliveliotis, Constantinos Constantinides, Meletios A Dimopoulos

Article2019

Risk for vascular thromboembolic events (VaTEs) in patients (pts) with advanced urinary tract cancer (aUTC) treated with chemotherapy.

Aristotelis Bamias, G. P. Tsironis, Ioannis Dimitriadis, Kimon Tzanis, Anna Tsiara, Aikaterini Xirokosta, Maria Kaparelou, Anastasios Kyriazoglou, Abis Cohen, D. Barbarousi, Konstantinos Koutsoukos, Michalis Liontos, Roubini Zakopoulou, Euthymios Kostouros, Stamatina Pagoni, Charis Matsouka, Meletios A Dimopoulos

Article2015

2608 A retrospective study of vascular thromboembolic events (VaTEs) in patients receiving first line treatment for advanced urothelial cancer (AUC)

I. Dimitriadis, G. P. Tsironis, Kimon Tzannis, Konstantinos Koutsoukos, E. Kostouros, Michalis Liontos, M. Lykka, E. Trajce, K. Nikolopoulos, Aggeliki Sfika, Eftychia Kafantari, Flora Zagouri, C. Matsouka, Meletios A Dimopoulos, A. Bamias

Article1998

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.

George Fountzilas, A. Athanassiades, Vaios Papadimitriou, Meletios A Dimopoulos, D. Bafaloukos, Gerasimos Aravantinos, C. Nicolaides, Haralabos P. Kalofonos, Pavlos Papakostas, Nikolaos I. Xiros, Esma Razi

Article2010

ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy.

A. Bamias, Nikitas Nikitas, Alexandra Karadimou, Dimitra Gika, Vasilios Karavasilis, Evangelos Briasoulis, Michael Chrisofos, Sara E. Murray, D. Pectasides, Meletios A Dimopoulos